Abstract | PURPOSE:
Tuberous sclerosis complex ( TSC) is an autosomal dominant disorder caused by inactivating mutations of the TSC1 or TSC2 gene, characterized by neurocognitive impairment and benign tumors of the brain, skin, heart, and kidneys. Lymphangioleiomyomatosis ( LAM) is a diffuse proliferation of α-smooth muscle actin-positive cells associated with cystic destruction of the lung. LAM occurs almost exclusively in women, as a TSC manifestation or a sporadic disorder (TSC1/TSC2 somatic mutations). Biomarkers of whole-body tumor burden/activity and response to rapalogs or other therapies remain needed in TSC/ LAM. EXPERIMENTAL DESIGN: These preclinical studies aimed to assess feasibility of [18F] fluorocholine (FCH) and [18F]fluoroacetate (FACE) as TSC/ LAM metabolic imaging biomarkers. RESULTS: We previously reported that TSC2-deficient cells enhance phosphatidylcholine synthesis via the Kennedy pathway. Here, we show that TSC2-deficient cells exhibit rapid uptake of [18F]FCH in vivo and can be visualized by PET imaging in preclinical models of TSC/ LAM, including subcutaneous tumors and pulmonary nodules. Treatment with rapamycin (72 hours) suppressed [18F]FCH standardized uptake value (SUV) by >50% in tumors. Interestingly, [18F]FCH-PET imaging of TSC2-deficient xenografts in ovariectomized mice also showed a significant decrease in tumor SUV. Finally, we found rapamycin-insensitive uptake of FACE by TSC2-deficient cells in vitro and in vivo, reflecting its mitochondrial accumulation via inhibition of aconitase, a TCA cycle enzyme. CONCLUSIONS: Preclinical models of TSC2 deficiency represent informative platforms to identify tracers of potential clinical interest. Our findings provide mechanistic evidence for testing the potential of [18F]FCH and [18F]FACE as metabolic imaging biomarkers for TSC and LAM proliferative lesions, and novel insights into the metabolic reprogramming of TSC tumors.
|
Authors | Eline E Verwer, Taylor R Kavanagh, William J Mischler, You Feng, Kazue Takahashi, Shuyan Wang, Timothy M Shoup, Ramesh Neelamegam, Jing Yang, Nicolas J Guehl, Chongzhao Ran, Walter Massefski, Ye Cui, Souheil El-Chemaly, Peter M Sadow, William M Oldham, Marie F Kijewski, Georges El Fakhri, Marc D Normandin, Carmen Priolo |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 24
Issue 23
Pg. 5925-5938
(12 01 2018)
ISSN: 1557-3265 [Electronic] United States |
PMID | 30054282
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | ©2018 American Association for Cancer Research. |
Chemical References |
- Biomarkers
- Fluoroacetates
- Phosphatidylcholines
- fluorocholine
- Choline
|
Topics |
- Aged
- Animals
- Biomarkers
- Choline
(analogs & derivatives)
- Disease Models, Animal
- Female
- Fluoroacetates
- Heterografts
- Humans
- Image Processing, Computer-Assisted
- Immunohistochemistry
- Lipid Metabolism
- Lymphangioleiomyomatosis
(diagnosis, etiology, metabolism)
- Male
- Mice
- Mice, Transgenic
- Mitochondria
(genetics, metabolism)
- Oxygen Consumption
- Phosphatidylcholines
(metabolism)
- Positron-Emission Tomography
(methods)
- Rats
- Tuberous Sclerosis
(diagnosis, etiology, metabolism)
|